View in EDS HTML Full Text PDF Full Text

Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer.

Saved in:
Bibliographic Details
Title: Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer.
Authors: Yılmaz, Feride1 (AUTHOR) doktorferide@gmail.com, Yaşar, Serkan1 (AUTHOR), Tatar, Ömer Denizhan2 (AUTHOR), Yıldırım, Hasan Çağrı3 (AUTHOR), Güven, Deniz Can4 (AUTHOR), Akyıldız, Arif1 (AUTHOR), Chalabiyev, Elvin1 (AUTHOR), Aktaş, Burak Yasin1 (AUTHOR), Arık, Zafer1 (AUTHOR), Erman, Mustafa1 (AUTHOR)
Source: BMC Cancer. 10/1/2024, Vol. 24 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-024-12935-x